作为m7G修饰相关酶的METTL1/WDR4和QKI在消化系统疾病中的功能
Wenyan Zhou1, Yan Yi2, Wenyu Cao3
1Department of Metabolism and Endocrinology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
Frontiers in pharmacology
|January 24, 2025
概括
修改N7-甲基瓜诺辛 (m7G) 对于RNA调节至关重要. 酶METTL1/WDR4和QKI与消化系统癌症和性结肠炎有关,强调它们在疾病中的作用.
科学领域:
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 胃肠病学 胃肠病学
背景情况:
- N7-甲基瓜诺辛 (m7G) 是一种普遍存在的RNA修饰,对RNA稳定性,翻译和核糖体识别至关重要.
- 该m7G修饰是由甲基转移酶样1 (METTL1) 和WD重复域4 (WDR4) 复合物催化.
- 震 (QKI) 蛋白识别内部m7G甲基化mRNA,调节翻译和稳定性.
研究的目的:
- 审查关于m7G甲基转移酶 (METTL1/WDR4) 和识别酶 (QKI) 在消化系统疾病中的作用的最新研究.
- 探索m7G修饰相关酶与消化系统癌症和炎症状况的关联.
主要方法:
- 最近研究的文献综述.
- 在消化系统疾病的背景下对METTL1/WDR4和QKI的研究分析.
- 专注于与结直肠癌,肝癌和性结肠炎相关的发现.
主要成果:
- m7G修饰酶METTL1/WDR4和QKI与消化系统癌症的发生有关.
- 这些酶也在其他消化系统疾病中发挥作用,例如性结肠炎.
- 最近的研究揭示了m7G相关酶和消化系统疾病进展之间的显著关联.
结论:
- METTL1/WDR4和QKI是导致消化系统疾病的分子机制的关键参与者.
- 针对m7G修饰途径可能为消化系统癌症和炎症性肠道疾病提供新的治疗策略.
- 需要进一步的研究,以充分阐明m7G修饰在消化系统健康和疾病中的复杂作用.
相关概念视频
Protein Modifications in the RER
5.0K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.0K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Protein Folding Quality Check in the RER
3.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


